跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Goclav-250 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Goclav-250
Approved
STANDARD
Goclav-250
Yeluri Formulations Pvt Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7e90ce99892786fe
Company
Yeluri Formulations Pvt Ltd
Type
Standard
Approval Details
Approval Id
7e90ce99892786fe
Drug Approval Philippines Name
Goclav-250
Product Name
Goclav-250
Registration Number
DRP-12921-02
Brand Name
Goclav-250
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Oral Suspension (Orange Flavor)
Dosage Strength
312.5 mg / 5 mL
Manufacturer
Yeluri Formulations Pvt Ltd
Importer
Medinova Pharmaceutical Inc
Distributor
Applied Pharmaceutical Distribution Inc.
Issuance Date
27 November 2023
Expiry Date
28 October 2027
Pharmacologic Category
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7e90ce99892786fe
Type
Standard
Back to Philippines FDA Approvals